ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 29459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 29459; 2) Community: the network communities that were significantly associated with the response to NSC 29459; 3) Molecule: the relationships between components within communities and NSC 29459; 4) MDR: the compounds that were significantly associated with the NSC 29459.

NSC Compound Enrichment Correlation
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0105244982742821 0.25049158
NSC 624205 Null 0.0105607789694647 0.19338456
NSC 628682 Null 0.0105607789694647 0.17272593
NSC 636087 Null 0.0105607789694647 0.1707581
NSC 645810 Null 0.0105607789694647 0.68627403
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 0.0105607789694647 0.50693077
NSC 673457 Null 0.0105607789694647 0.21123327
NSC 673458 Null 0.0105607789694647 0.1704018
NSC 674964 Spiro[s-indacene-2(1H),2'-[2H]indene]-8-carboxylic acid, 3,5,6,7,1',3'-hexahydro-3'-oxo- 0.0105607789694647 0.20218202
NSC 681640 Camptothecin Derivative 0.0105607789694647 0.72619593
Total:71  Current:22    [First] [Prev] [Next] [Last]